<DOC>
	<DOCNO>NCT00693472</DOCNO>
	<brief_summary>This study design evaluate effectiveness preladenant prevention ( Part 1 ) treatment ( Part 2 ) antipsychotic induce akathisia subject acute psychosis use Barnes Akathisia Scale .</brief_summary>
	<brief_title>Study Preladenant Treatment Neuroleptic Induced Akathisia ( Study P05145AM1 ) ( COMPLETE )</brief_title>
	<detailed_description />
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Akathisia , Drug-Induced</mesh_term>
	<mesh_term>Cholinergic Antagonists</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Subjects guardian must willing give write informed consent . Part 1 Only : Subjects acute ( drug relate ) psychoses PANSS score least 60 : schizophrenia , schizoaffective , schizomanic , acute mania history previous treatment neuroleptic . Part 1 Only : Subjects initiate haloperidol treatment acute psychotic episode dose least 7.5 mg per day . Part 2 Only : Inpatient subject develop akathisia result haloperidol &gt; =5 mg per day treatment acute psychosis . The enrollment subject receive neuroleptic allow consultation agreement sponsor . Subjects either sex race age 18 65 year , inclusive . Subjects ' clinical laboratory test ( CBC , blood chemistry , urinalysis ) must within normal limit clinically acceptable investigator/sponsor . Subject 's liver function test result ( ie , AST , ALT ) must elevate normal limit Screening Day 1/1 . Subjects must free clinically significant disease psychosis would interfere study evaluation . Screening ECG must clinically acceptable investigator . Female childbearing potential must : Have use medically accepted method contraception 1 month ( abstain sexual intercourse ) prior screen period . An acceptable method contraception include one following : condom ( male female ) ~ spermicide , diaphragm cervical cap ~ spermicide condom , stable oral/transdermal/injectable hormonal contraceptive regimen without breakthrough uterine bleed 2 month prior Screening visit condom ~ spermicide , intrauterine device ( insert least 2 month prior Screening visit ) use spermicide . Note : Vasectomy partner consider sufficient contraception one 4 bulleted method list must use . Agree use one accept method contraception ( list ) trial ( include screen period prior receive trial medication ) , 1 month stop trial medication . Subjects enrol placebo arm Part 1 develop akathisia may eligible Part 2 standard care arm . Subjects positive screen drug high potential abuse . Subjects screen positive cannabis permit . Subjects previously receive compound . Subjects currently participate another clinical study participate clinical study within 30 day ( excepted subject enrol Part 1 P05145 study ) . Subjects part study staff personnel family member study staff personnel . Subjects severe/uncontrolled hypertension exclude . Subjects hypertension well control stable dose standard antihypertensive medication ( exclude betablockers ) eligible . Subjects history coronary artery disease include MI , cerebrovascular disease ( stroke , TIA ) , peripheral arterial disease . Subjects congestive heart failure subject ECGs consistent ischemic heart disease , sick sinus syndrome significant Q wave . Subjects find immediate risk suicide . Female subject pregnant nursing . Subjects treat Clozapine exclude . A washout period 6 month prior dose acceptable study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Antipsychotic Agents</keyword>
</DOC>